与败血症相关的血管内凝血中的器官功能障碍
Juntendo Iji zasshi = Juntendo medical journal
|June 10, 2024
概括
在败血症中,传播性血管内凝血 (DIC) 通过引起微血管血栓和损害组织输液,导致器官损伤. 了解这种血栓炎症是治疗败血症和急性损伤 (AKI) 的关键.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 败血症往往导致扩散性血管内凝血 (DIC) 和多个器官损伤.
- 越来越多地认识到DIC是导致败血症器官功能障碍的原因,而不仅仅是其并发症.
- 微血管血栓形成会损害组织输液,导致器官损伤.
研究的目的:
- 阐明血栓炎症在败血症相关的DIC和器官功能障碍中的作用.
- 要突出连接败血症,DIC和急性损伤 (AKI) 的机制.
主要方法:
- 审查关于败血症病理生理学的现有文献.
- 分析涉及中性粒细胞,血小板,内皮损伤和凝血/纤维溶解失衡的机制.
主要成果:
- 败血症相关的DIC涉及由活性中性粒细胞,血小板和内皮损伤驱动的血栓炎症.
- 在DIC中微血管血栓形成导致组织输液受损和器官损伤,特别是AKI.
- 败血症中AKI的严重程度与败血症和DIC的严重程度密切相关.
结论:
- 血栓炎症是与败血症相关的DIC和器官损伤的中心机制.
- 了解这些途径对于有效的败血症管理至关重要,特别是在AKI方面.
- 向血栓栓塞路径可能为败血症引起的器官功能障碍提供治疗策略.
相关概念视频
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
Coagulation
6.2K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.2K
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675


